HAVCR2 and glioblastoma: One immunoregulatory molecule that has not been thoroughly targeted in glioblastoma-based clinical trials is T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3, encoded by the HAVCR2 gene).